David Chetrit, MD
Rheumatology · Myrtle Beach, SCNPI 1285155010
Payments from drug & device makers
Across 524 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$2K
- Johnson & Johnson$1K
- UCB, Inc.$795
- Novartis$683
- Novo Nordisk$211
- plus $1K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 127 | $2,229 |
| Amgen(2 entities) | 140 | $1,853 |
| Johnson & Johnson | 69 | $1,094 |
| UCB, Inc. | 63 | $795 |
| Novartis | 44 | $683 |
| Novo Nordisk | 9 | $211 |
| E.r. Squibb & Sons, L.L.C. | 10 | $156 |
| Boehringer Ingelheim | 7 | $130 |
| Radius Health, Inc. | 7 | $116 |
| Pfizer | 7 | $102 |
| Averitas Pharma Inc. | 3 | $78 |
| Calliditas Therapeutics US Inc. | 3 | $70 |
| Aurinia Pharma U.S., Inc. | 3 | $63 |
| Mallinckrodt Hospital Products Inc. | 3 | $59 |
| GSK | 4 | $56 |
| Kyowa Kirin, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Bayer | 3 | $43 |
| Genentech USA, Inc. | 2 | $40 |
| Boston Scientific | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| AstraZeneca | 2 | $32 |
| Organon | 1 | $28 |
| GRT US Holding, Inc. | 1 | $27 |
| Medicomp Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Electromed, Inc. | 1 | $18 |
| Janssen Scientific Affairs, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Halozyme Inc | 1 | $15 |
| Insulet Corporation | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$8,171 in reported general payments places this provider in the 55th percentile of 123 rheumatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Myrtle Beach
- Douglas ConawayMyrtle Beach$507K
- David LazarMyrtle Beach$113K
- Gerald LarochelleMyrtle Beach$24K
- Wendy LeeMyrtle Beach$24K
- Rabih NayfeMyrtle Beach$21K
- Jon TwiningMyrtle Beach$14K
- Clarence LegertonSummerville$7.7M
- Gary FinkSummerville$6.9M
- William EdwardsSummerville$5.9M
- Colin EdgertonSummerville$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.